PREMIUM
AIM IHT
US approval | Successful sale | Angling success
News covered here includes our assessment of pleasing results from a specialist fishing tackle retailer, although margins are slim and overseas expansion looks puzzling to us. Elsewhere in the retail world, trading remains tough for a seller of cosmetics, as it does for a specialist audio visual group. Read on here for our usual forthright views on this and other news.
Those interested in big dividend paying companies on AIM, of which there are a growing number, should take a look at our AIM for High Yield Portfolio here. Onto our thoughts on the latest news....
Tristel: another product approval bodes well
Tristel (AIM: TSTL), the manufacturer of infection prevention products, has received clearance from the US FDA for the immediate sale of Tristel OPH, it’s high-level disinfectant ("HLD") foam, for use on ophthalmic medical…
Continue reading our content…
Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
- Unlimited access to our market-beating portfolios
- In-depth coverage of many of the world’s great companies
- Unique insights from our top research team
Register FREE for access to limited content.
- Company and markets insights
- Sponsored content
- Podcasts
Previous article
